OB | IBN | Total new bone | β-TCP HA | |
---|---|---|---|---|
Bone walls plasma | 12.1 ± 6.4 (8.1; 16.1) | 5.2 ± 5.5 (1.8; 8.6) | 17.3 ± 10.7 (10.6; 23.9) | 42.7 ± 9.7 (36.7; 48.8) |
Bone wall control | 11.5 ± 7.8 (6.7; 16.4) | 5.1 ± 5.7 (1.6; 8.7) | 16.6 ± 11.7 (9.4; 23.9) | 46.5 ± 11.8 (39.2; 53.8) |
p | 0.646 | 0.635 | 0.575 | 0.169 |
Central plasma | 2.1 ± 3.1 (0.2; 4.1) | 1.0 ± 1.8 (− 0.1; 2.1) | 3.1 ± 4.1 (0.6; 5.7) | 58.0 ± 15.1 (48.6; 67.3) |
Central control | 2.1 ± 2.7 (0.5; 3.8) | 1.9 ± 3.4 (− 0.2; 4.0) | 4.0 ± 5.7 (0.5; 7.6) | 59.9 ± 9.4 (54.1; 65.7) |
p | 1.000 | 0.465 | 0.345 | 0.721 |
Sub-mucosa plasma | 6.9 ± 9.3 (1.2; 12.6) | 2.4 ± 2.9 (0.6; 4.1) | 9.3 ± 11.9 (1.9; 16.7) | 55.1 ± 13.7 (46.6; 63.6) |
Sub-mucosa control | 4.0 ± 4.5 (1.2; 6.8) | 5.3 ± 6.9 (1.0; 9.6) | 9.4 ± 11.4 (2.3; 16.4) | 51.7 ± 13.3 (43.4; 59.9) |
p | 0.310 | 0.075 | 0.866 | 0.284 |
Close-to-window plasma | 3.3 ± 4.5 (0.5; 6.1) | 0.6 ± 2.0 (− 0.6; 1.9) | 4.0 ± 6.3 (0.1; 7.9) | 56.3 ± 15.3 (46.8; 65.8) |
Close-to-window control | 5.2 ± 5.4 (1.9; 8.6) | 2.5 ± 3.6 (0.3; 4.7) | 7.7 ± 8.0 (2.8; 12.7) | 52.6 ± 14.9 (43.4; 61.9) |
p | 0.271 | 0.068 | 0.128 | 0.767 |